Allred Capital Management, LLC Incyte Corp Transaction History

Allred Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$79.87 - $87.53 $9,504 - $10,416	-119 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$76.02 - $100.5 $3,344 - $4,422	44 Added 58.67%	119 $0
Q1 2020 Apr 17, 2020	SELL	$63.18 - $85.97 $2,653 - $3,610	-42 Reduced 35.9%	75 $5.49 Million
Q4 2019 Jan 13, 2020	BUY	$73.04 - $95.72 $8,545 - $11,199	117 New	117 $0

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.